The Scientist selects Aspect Imaging's M2 imaging platform as one of Top 10 Innovations of 2011

NewsGuard 100/100 Score

M2™ Platform Recognized for the Significant Innovation that it Provides to the Pre-Clinical Imaging Marketplace

The Scientist today unveiled the Top 10 Innovations of 2011 and selected Aspect Imaging's M2™ compact high-performance MRI imaging system as one the winners of this award. The Scientist invited members of the life science community to submit descriptions of exciting tools that made an impact in research this year and asked a panel of expert judges to evaluate the technologies. "The 2011 winners represent an exceptional combination of ingenuity and technical advances," said Mary Beth Aberlin, Editor-in-Chief of The Scientist.

"We are thrilled that The Scientist and their expert panel selected our M2 imaging platform as one of the 'Top 10 Innovations' in life science," says Uri Rapoport, Aspect Imaging's Founder and CEO. "With the rapid adoption of our technology and the growing use of our M2 MRI system globally to quantify biomarkers in vivo, we are most proud of the new insights that our customers in research and drug development are deriving by using our M2 platform. This award is further recognition as to the value MRI and most specifically - - the M2 high-performance compact MRI system - - is providing to the life scientist to quantify the expression of disease, to monitor disease progression and to assess therapeutic efficacy and response in vivo".

SOURCE Aspect Imaging

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Deep learning shines a new light on Parkinson's detection through the eye